The JAK2V617F mutation can occur in a hematopoietic stem cell that exhibits no proliferative advantage: a case of human allogeneic transplantation

Blood. 2008 Aug 1;112(3):921-2. doi: 10.1182/blood-2008-04-154708.
No abstract available

Publication types

  • Case Reports
  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Cell Proliferation
  • Female
  • Hematopoietic Stem Cell Transplantation
  • Hematopoietic Stem Cells*
  • Humans
  • Janus Kinase 2 / genetics*
  • Mutation, Missense*
  • Myelodysplastic Syndromes / therapy
  • Transplantation, Homologous

Substances

  • JAK2 protein, human
  • Janus Kinase 2